Celia Padron
General Practice · Doral, FLNPI 1013961705
Payments from drug & device makers
Across 54 payments — averaging $16,820 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$513K
- AstraZeneca$229K
- AbbVie$145K
- Boehringer Ingelheim Pharma GmbH & Co.kg$12K
- UCB Biosciences Inc.$9K
- Chiesi USA, Inc.$519
- plus $123 from 1 others
What the payments were for
- Travel & lodging$39443%
- Food & beverage$52057%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 5 | $512,880 |
| AstraZeneca(2 entities) | 3 | $228,723 |
| AbbVie(2 entities) | 22 | $145,140 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 6 | $11,731 |
| UCB Biosciences Inc. | 2 | $9,150 |
| Chiesi USA, Inc. | 2 | $519 |
| QOL Medical, LLC | 14 | $123 |
How this compares
$908,268 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Allopurinol | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other general practice in Doral
- Aleida HernandezDoral$1.8M
- Jose CardonaMiami$71M
- Lawrence GalitzMiami Gardens$42.5M
- Armando AcevedoMiami$15.2M
- Jorge AmayaMiami$14.2M
- Frank AlvarezHialeah$13.6M
- Hector RodriguezMiami$12.8M
- Eddie ArmasSouth Miami$12.4M
- Idalia AcostaMiami$11.4M
- Lilia Rodriguez AblesMiami$10.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.